Parsons Capital Management Inc Abbott Laboratories Transaction History

Parsons Capital Management Inc

$1.55 Billion
Q3 2024

A detailed history of Parsons Capital Management Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Parsons Capital Management Inc holds 71,595 shares of ABT stock, worth $8.22 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares

71,595

Previous 74,327 3.68%

Holding current value

$8.22 Million

Previous $7.72 Million 5.68%

% of portfolio

0.53%

Previous 0.53%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$100.07 - $118.13 $273,391 - $322,731	-2,732 Reduced 3.68%	71,595 $8.16 Million
Q2 2024 Jul 19, 2024	SELL	$100.73 - $112.44 $323,242 - $360,819	-3,209 Reduced 4.14%	74,327 $7.72 Million
Q1 2024 Apr 22, 2024	SELL	$109.52 - $120.96 $267,447 - $295,384	-2,442 Reduced 3.05%	77,536 $8.81 Million
Q4 2023 Jan 22, 2024	SELL	$90.19 - $110.4 $174,066 - $213,072	-1,930 Reduced 2.36%	79,978 $8.8 Million
Q3 2023 Nov 06, 2023	BUY	$95.53 - $114.62 $35,823 - $42,982	375 Added 0.46%	81,908 $7.93 Million
Q2 2023 Aug 04, 2023	BUY	$100.78 - $112.29 $22,473 - $25,040	223 Added 0.27%	81,533 $8.89 Million
Q1 2023 Apr 17, 2023	SELL	$96.86 - $114.01 $331,261 - $389,914	-3,420 Reduced 4.04%	81,310 $8.23 Million
Q4 2022 Feb 13, 2023	BUY	$95.06 - $111.52 $20,057 - $23,530	211 Added 0.25%	84,730 $9.3 Million
Q3 2022 Oct 26, 2022	SELL	$96.76 - $112.03 $11,611 - $13,443	-120 Reduced 0.14%	84,519 $8.18 Million
Q2 2022 Jul 29, 2022	SELL	$102.07 - $123.37 $174,437 - $210,839	-1,709 Reduced 1.98%	84,639 $9.2 Million
Q1 2022 May 02, 2022	SELL	$114.02 - $139.04 $41,845 - $51,027	-367 Reduced 0.42%	86,348 $10.2 Million
Q4 2021 Feb 07, 2022	SELL	$115.53 - $141.46 $58,342 - $71,437	-505 Reduced 0.58%	86,715 $12.2 Million
Q3 2021 Nov 09, 2021	SELL	$116.66 - $129.06 $125,176 - $138,481	-1,073 Reduced 1.22%	87,220 $10.3 Million
Q2 2021 Aug 03, 2021	SELL	$105.79 - $124.53 $196,769 - $231,625	-1,860 Reduced 2.06%	88,293 $10.2 Million
Q1 2021 Apr 28, 2021	SELL	$108.84 - $128.23 $136,811 - $161,185	-1,257 Reduced 1.38%	90,153 $10.8 Million
Q4 2020 Feb 08, 2021	SELL	$105.0 - $114.42 $107,940 - $117,623	-1,028 Reduced 1.11%	91,410 $10 Million
Q3 2020 Oct 29, 2020	SELL	$91.64 - $111.29 $8,155 - $9,904	-89 Reduced 0.1%	92,438 $10.1 Million
Q2 2020 Aug 10, 2020	BUY	$76.57 - $98.0 $100,230 - $128,282	1,309 Added 1.44%	92,527 $8.46 Million
Q1 2020 May 05, 2020	SELL	$62.82 - $91.86 $684,738 - $1 Million	-10,900 Reduced 10.67%	91,218 $7.2 Million
Q4 2019 Feb 03, 2020	SELL	$78.51 - $87.4 $101,670 - $113,183	-1,295 Reduced 1.25%	102,118 $8.87 Million
Q3 2019 Nov 12, 2019	SELL	$81.84 - $88.74 $85,850 - $93,088	-1,049 Reduced 1.0%	103,413 $8.65 Million
Q2 2019 Aug 01, 2019	SELL	$72.88 - $85.0 $269,801 - $314,670	-3,702 Reduced 3.42%	104,462 $8.79 Million
Q1 2019 Apr 26, 2019	SELL	$66.22 - $80.06 $85,887 - $103,837	-1,297 Reduced 1.18%	108,164 $8.65 Million
Q4 2018 Feb 01, 2019	SELL	$65.56 - $74.27 $85,621 - $96,996	-1,306 Reduced 1.18%	109,461 $7.92 Million
Q3 2018 Nov 13, 2018	SELL	$60.81 - $73.36 $104,289 - $125,812	-1,715 Reduced 1.52%	110,767 $8.13 Million
Q2 2018 Aug 09, 2018	SELL	$57.57 - $63.54 $20,955 - $23,128	-364 Reduced 0.32%	112,482 $0
Q1 2018 May 07, 2018	SELL	$56.27 - $63.62 $93,689 - $105,927	-1,665 Reduced 1.45%	112,846 $6.76 Million
Q4 2017 Feb 02, 2018	SELL	$53.68 - $57.47 $108,702 - $116,376	-2,025 Reduced 1.74%	114,511 $6.54 Million
Q3 2017 Oct 26, 2017	BUY	$48.06 - $53.64 $5.6 Million - $6.25 Million	116,536	116,536 $6.22 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parsons Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Parsons Capital Management Inc with notifications on news.

Account

Parsons Capital Management Inc Abbott Laboratories Transaction History